Brain-derived extracellular vesicles play a dual role in neurodegenerative disorders by acting as carriers of disease-spreading signals and serving as potential diagnostic biomarkers and therapeutic tools.
Neurodegenerative disorders are one of the most common causes of disability and represent 6.3% of the global burden of disease. Among them, Alzheimer's, Parkinson's, and Huntington's diseases cause cognitive decline, representing the most disabling symptom on both personal and social levels. The molecular mechanisms underlying the onset and progression of dementia are still poorly understood, and include secretory factors potentially affecting differentiated neurons, glial cells and neural stem cell niche. In the last decade, much attention has been devoted to exosomes as novel carriers of information exchanged among both neighbouring and distant cells. These vesicles can be generated and internalized by different brain cells including neurons, neural stem cells, astrocytes, and microglia, thereby affecting neural plasticity and cognitive functions in physiological and pathological conditions. Here, we review data on the roles of exosomes as carriers of bioactive molecules potentially involved in the pathogenesis of neurodegenerative disorders and detectable in biological fluids as biomarkers of dementia. We also discuss the experimental evidence of the therapeutic potential of stem cell-derived vesicles in experimental models of neurodegeneration-dependent cognitive decline.
Natale et al. (Sun,) conducted a review in Neurodegenerative disorders (Alzheimer's, Parkinson's, Huntington's diseases). Extracellular vesicles was evaluated. Brain-derived extracellular vesicles play a dual role in neurodegenerative disorders by acting as carriers of disease-spreading signals and serving as potential diagnostic biomarkers and therapeutic tools.